Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii

Dana R. Bowers, Henry Cao, Jian Zhou, Kimberly R. Ledesma, Dongxu Sun, Olga Lomovskaya, Vincent H. Tam
Dana R. Bowers
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry Cao
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Zhou
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly R. Ledesma
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongxu Sun
2Rempex Pharmaceuticals, San Diego, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Lomovskaya
2Rempex Pharmaceuticals, San Diego, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent H. Tam
1Department of Clinical Sciences and Administration, University of Houston College of Pharmacy, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vtam@uh.edu
DOI: 10.1128/AAC.04110-14
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Antimicrobial resistance among Acinetobacter baumannii is increasing worldwide, often necessitating combination therapy. The clinical utility of using minocycline with polymyxin B is not well established. In this study, we investigated the activity of minocycline and polymyxin B against 1 laboratory and 3 clinical isolates of A. baumannii. Minocycline susceptibility was performed with and without an efflux pump inhibitor, phenylalanine-arginine β-naphthylamide (PAβN). Intracellular minocycline concentration was determined with and without polymyxin B (0.5 μg/ml). Time-kill studies were performed over 24h using approximately 106 CFU/mL of each strain with clinically relevant minocycline concentrations (2 μg/ml and 8 μg/ml), with and without polymyxin B (0.5 μg/ml). In vivo efficacy of the combination was assessed in a neutropenic murine pneumonia model. Infected animals were administered minocycline (50 mg/kg), polymyxin B (10 mg/kg) or both to achieve clinically equivalent exposures in humans. Reduction in minocycline MIC (≥ 4x) was observed in the presence of PAβN. Intracellular concentration and in vitro bactericidal effect of minocycline were both enhanced by polymyxin B. In 2 minocycline-susceptible strains, bacterial burden in lung tissue at 24h was considerably reduced by the combination group compared to monotherapy of minocycline or polymyxin B. In addition, the combination prolonged survival of animals infected with a minocycline-susceptible strain. Polymyxin B increased intracellular concentration of minocycline in bacterial cells and enhanced the bactericidal activity of minocycline, presumably due to efflux pump disruption. The clinical utility of this combination should be further investigated.

FOOTNOTES

  • ↵*Corresponding author and mailing address: University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030, Phone: (832) 842-8316; Fax: (832) 842-8383; E-mail: vtam{at}uh.edu
  • Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Next
Back to top
Download PDF
Citation Tools
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
Dana R. Bowers, Henry Cao, Jian Zhou, Kimberly R. Ledesma, Dongxu Sun, Olga Lomovskaya, Vincent H. Tam
Antimicrobial Agents and Chemotherapy Feb 2015, AAC.04110-14; DOI: 10.1128/AAC.04110-14

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
Dana R. Bowers, Henry Cao, Jian Zhou, Kimberly R. Ledesma, Dongxu Sun, Olga Lomovskaya, Vincent H. Tam
Antimicrobial Agents and Chemotherapy Feb 2015, AAC.04110-14; DOI: 10.1128/AAC.04110-14
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596